← Back to Search

Gabi System for Premature Infant Diseases (BRIDGE Trial)

N/A
Waitlist Available
Research Sponsored by Gabi SmartCare
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at the end of the 3-month period for each participant
Awards & highlights

BRIDGE Trial Summary

This trialwill assess the potential clinical utility of a system that monitors SpO2, pulse rate, respiratory rate and movements of children < 6 with underlying medical conditions. Caregivers and HCPs will also assess its usability.

Eligible Conditions
  • Premature Infant Diseases
  • Cardiovascular Disease
  • Congenital Heart Defects
  • Respiratory Diseases
  • Chronic Respiratory Disease
  • Chronic Obstructive Pulmonary Disease

BRIDGE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at the end of the 3-month period for each participant
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at the end of the 3-month period for each participant for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Caregiver Usability
Clinical Utility
HCP Usability

BRIDGE Trial Design

1Treatment groups
Experimental Treatment
Group I: Gabi SystemExperimental Treatment1 Intervention
Subjects will wear the Gabi system each time they go to sleep or are resting, to measure and record their SpO2, pulse rate, respiratory rate and movements.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gabi System
2022
N/A
~110

Find a Location

Who is running the clinical trial?

Gabi SmartCareLead Sponsor
2 Previous Clinical Trials
114 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~32 spots leftby Apr 2025